The nitrilase-mediated pathway has significant advantages in the production of optically pure aromatic ␣-hydroxy carboxylic acids. However, low enantioselectivity and activity are observed on hydrolyzing o-chloromandelonitrile to produce optically pure (R)-o-chloromandelic acid. In the present study, a protein engineering approach was successfully used to enhance the performance of nitrilase obtained from Burkholderia cenocepacia strain J2315 (BCJ2315) in hydrolyzing o-chloromandelonitrile. O ptically pure aromatic ␣-hydroxy carboxylic acids, such as mandelic acid and its derivatives, are widely used as intermediates and resolving agents for the production of many pharmaceutical and agricultural products (1, 2). Among them, (R)-ochloromandelic acid is one of the most preferred chiral building blocks for industrial synthesis of the antithrombotic agent (S)-clopidogrel, commercialized under the brand name Plavix (3, 4).Considering the great importance of (R)-o-chloromandelic acid in pharmaceuticals and the ever-growing demand for green catalytic processes, tremendous efforts have been made to establish enantioselective routes of production (1). Among them, the nitrilase-mediated pathway is a simple and practical approach for the commercial production of (R)-o-chloromandelic acid and its derivatives because it does not involve a cofactor, uses a less-expensive starting material, and theoretically yields 100% of the desired product.However, few nitrilases have been identified with high enantioselectivity and activity toward o-chloromandelonitrile (2, 3, 5-7). This severely reduces the practical applications of nitrilasemediated production of optically pure (R)-o-chloromandelic acid. A nitrilase with high enantioselectivity and specific activity is crucial to fit the manufacturing process and reduce industrial production costs. These requirements may be met by discovering new enzymes or by applying protein engineering to enhance the performance of the existing nitrilases, and convincing successes have been achieved by both methods (8).In our previous study, we identified and characterized a novel arylacetonitrilase, BCJ2315, from Burkholderia cenocepacia strain J2315 (9). BCJ2315 demonstrated high activity toward o-chloromandelonitrile and tolerated up to 50 mM o-chloromandelonitrile, though the o-chloromandelonitrile was highly toxic to the enzyme, demonstrating great potential for production of (R)-ochloromandelic acid under high o-chloromandelonitrile concentrations (4). Unfortunately, BCJ2315 showed relatively low enantioselectivity toward o-chloromandelonitrile, providing the desired product with only 89.2% enantiomeric excess (ee), which reduces its value for industrial production of (R)-o-chloromandelic acid (4).In the present study, we aspired to improve the fitness of BCJ2315 for the hydrolysis of o-chloromandelonitrile to efficiently produce (R)-o-chloromandelic acid. A protein engineering approach was successfully used to improve the enantioselectivity and activity of BCJ2315 by changing the enzyme structu...